EUVIMEDEUVIMED entdecken
KommentarOpen Access

An antisense antidote to oncogenic poison exons

René M Arvola, Guramrit Singh

Genes & Development · 2026

DOI: 10.1101/gad.353988.126 ↗

Kurz gefasst

Kommentar in der Zeitschrift Genes & Development, 2026. Verfasst von René M Arvola und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Center for RNA Biology, The Ohio State University, Columbus, Ohio 43210, USA. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, Exons. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Splicing factors are frequently mutated in myeloid cancers, causing splicing aberrations that derail the expression of tumor suppressor genes. In SRSF2 mutated cancers, a key oncogenic splicing event is the inclusion of a “poison” exon that introduces an early stop codon in EZH2 mRNA, causing its destabilization. In this issue of Genes & Development , Islam et al. (doi:10.1101/gad.353628.126) define how mutant SRSF2 binding to the poison exon mediates its inclusion and identify an antisense oligonucleotide that represses the exon to restore EZH2 function and rescues hematopoietic defects. Thus, targeting of poison exons, many of which show protumorigenic and antitumorigenic properties, is a promising new avenue to treat cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oligonucleotides, AntisenseExonsHumansEnhancer of Zeste Homolog 2 ProteinRNA SplicingAnimalsSerine-Arginine Splicing Factors

Stichwörter der Autor:innen

RNA splicingantisense oligonucleotide therapycancergene expressionnonsense-mediated mRNA decay

Substanzen

Oligonucleotides, AntisenseEnhancer of Zeste Homolog 2 ProteinSerine-Arginine Splicing Factors

Autor:innen und Institutionen

  • Department of Molecular Genetics, Center for RNA Biology, The Ohio State University, Columbus, Ohio 43210, USA.
  • Department of Molecular Genetics, Center for RNA Biology, The Ohio State University, Columbus, Ohio 43210, USA singh.734@osu.edu.

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Arvola, R. M., & Singh, G. (2026). An antisense antidote to oncogenic poison exons. Genes & Development. https://doi.org/10.1101/gad.353988.126

Vancouver

Arvola RM, Singh G. An antisense antidote to oncogenic poison exons. Genes & Development. 2026. doi:10.1101/gad.353988.126

BibTeX
@article{Arvola2026,
  author = {Arvola, René M and Singh, Guramrit},
  title = {An antisense antidote to oncogenic poison exons},
  journal = {Genes & Development},
  year = {2026},
  doi = {10.1101/gad.353988.126}
}
Kostenlos starten →